Half-yearly report on the liquidity contract of Sartorius Stedim Biotech

On December 31, 2024, Sartorius Stedim Biotech, via Kepler Cheuvreux, presented its half-yearly balance sheet for the liquidity contract. As of that date, the liquidity account showed 29,563 shares as well as €6,232,769.05 in cash. During the half-year, 5,450 purchase transactions for 281,035 shares and €49,893,952.42 were carried out. On the sales side, 5,333 transactions allowed 297,764 shares to be sold for €53,521,926.85.

Compared to June 30, 2024, the account had 46,292 shares and €2,521,189.91 in cash. Purchase transactions amounted to 6,493 for 305,402 shares and an amount of €69,412,550.00, while 5,322 sale transactions accounted for 273,281 shares and €63,664,027.43.